Navigation Links
Health Robotics Announces First Five i.v.STATION(TM) Robot Shipments and Receipt of 3L/3T Innovation Award
Date:10/12/2009

rug exchange and accuracy mistakes, high costs, life-critical turn-around time, intravenous drugs waste, regulatory issues, and difficulty in maintaining adequately trained clinical staff. i.v.STATION automatically and aseptically compounds non-hazardous IV doses and dispenses them to clinical staff in a ready-to-administer patient formats for antibiotics, pain therapy, anti-virals, epidurals, and other IVs and injectable medications. i.v.STATION was designed to address the above-mentioned industry-challenges, and to overcome the fact that until now, the range of products and technology available to mitigate these widespread industry patient safety and financial problems has consisted of variations on the IV "piggyback" bag, outsourcing of IVs, and 1990s-developed automated "solutions" that have seen little or no adoption and success over the past twenty years.

"These first five shipments of i.v.STATION represent the culmination of extraordinary work by our engineers and beta test customers and, I hope, also the start of a new era for Health Robotics in bringing our robots and software automation solutions out of the pharmacy basement and into the nurse stations [wards] and satellite pharmacies, as close as we can get to the patients. I feel bad for all of our 9 American beta test customers that have suffered delays solely due to the ill advised and frivolous litigation threats to their institutions by the distributor we terminated for cause in North America. We are nevertheless proceeding with installations at some of these 9 hospitals this month, while we will have no other choice but to substitute some of these 9 beta sites with other American hospitals, as solely decided by these 9 beta site hospitals on a case-by-case basis, based on their response to the litigation threats frivolously made against them by Devon Robotics. I also hope to announce our new partnership in North America for i.v.STATION over the next few weeks, but in any event before
'/>"/>

SOURCE Health Robotics SRL
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Frost & Sullivans 2009 Excellence in Healthcare Awards Banquet Honours Industrys Top Performers
2. OncoGenex Pharmaceuticals CEO Named Canadas Pacific Ernst & Youngs Entrepreneur Of The Year(R) in the Health Sciences Category
3. Healthnostics Medbioworld.com Portal Web Site to Include Social Networking Features
4. Nanomedicine Company Focuses on Improving Premature Infant Health and Reducing Death Rate
5. avVaa World Health Care Products Inc. Announces DRTV Test Television Stations
6. GetReel Health and CheckOrphan Partner to Help Rare, Orphan and Neglected Diseases
7. avVaa World Health Care Products Inc. Announces Second DRTV Test Week
8. Healthnostics Unveils Biomedical Content Strategy for Medbioworld.com
9. Spain's Health Ministry Contracts Authenware to Fortify System Security Prior to Flu Season
10. DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
11. Global Public Health the Focus of Scientific Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... DIEGO , Aug. 3, 2015  Halozyme Therapeutics, ... Update Conference Call for the second quarter 2015 on ... PT. Dr. Helen Torley , president and chief ... date post-market, Halozyme will release financial results for the ... webcast live through the "Investors" section of Halozyme,s corporate ...
(Date:8/3/2015)... 3, 2015  Merck KGaA, Darmstadt, Germany ... high-tech products in the healthcare, life science and performance ... Nano-C, their development and launch of promising new fullerene ... Merck KGaA, Darmstadt, Germany , is ... sector. Novel derivatives: highly stable, easy to ...
(Date:8/3/2015)... NEW YORK , August 3, 2015 ... "Global Market Study on 3D Cell Culture: ... published by Persistence Market Research, the global 3D cell culture ... is expected to expand at a CAGR of 29.1% ... View Full Report with TOC:  http://www.persistencemarketresearch.com/market-research/3d-cell-cultures-market.asp ...
(Date:7/31/2015)... China Cord Blood Corporation (NYSE: CO) ("CCBC" ... provider of cord blood collection, laboratory testing, hematopoietic stem ... that the Company has filed its Annual Report on ... The filed Form 20-F includes audited financial statements for ... 20-F can be accessed by visiting the U.S. Securities ...
Breaking Biology Technology:Halozyme to Host Second Quarter 2015 Financial Results Conference Call 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 2Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 3Global 3D Cell Culture Market Will Reach US$ 2,717.6 Million by 2020: Persistence Market Research 4China Cord Blood Corporation Files Its Annual Report on Form 20-F 2
... Prevalence and Roles of miRNAs , ... cloned , and sequenced from human ... apparently regulates multiple genes, and miRNAs are thought to , ... predict mRNA target sites for miRNAs [2,3]. A handful of these , ...
... Construction Kit , Prepare your probe in ... Ideal for siRNA/miRNA studies , ... high specific , activity RNA probes for RPA, Northern, Southern, ... No cloning required , ...
... , with a fluorometer capable of ... ultra-sensitive assay for determining RNase A specific activity. The , ... including RNase A, T1, RNase I, micrococcal ... nuclease, and Benzonase. In addition to detecting , ...
Cached Biology Technology:Reagents for Up and Down-Regulation of miRNA Activity in Mammalian Cells 2Reagents for Up and Down-Regulation of miRNA Activity in Mammalian Cells 3Reagents for Up and Down-Regulation of miRNA Activity in Mammalian Cells 4Reagents for Up and Down-Regulation of miRNA Activity in Mammalian Cells 5Reagents for Up and Down-Regulation of miRNA Activity in Mammalian Cells 6Reagents for Up and Down-Regulation of miRNA Activity in Mammalian Cells 7Reagents for Up and Down-Regulation of miRNA Activity in Mammalian Cells 8Reagents for Up and Down-Regulation of miRNA Activity in Mammalian Cells 9Prepare siRNA and miRNA Probes in Just 1 Hour 2Prepare siRNA and miRNA Probes in Just 1 Hour 3Measuring RNase Activity A Real-time Kinetic Analysis 2Measuring RNase Activity A Real-time Kinetic Analysis 3Measuring RNase Activity A Real-time Kinetic Analysis 4Measuring RNase Activity A Real-time Kinetic Analysis 5
(Date:7/21/2015)... 21, 2015 Passwords have proven futile ... the recent U.S. Office of Personnel Management breach. ... infosec conundrum, but developers and end-users are concerned ... this dilemma, Biometrics-as-a-Service provider HYPR Corp. announced today ... for third party integration. A ...
(Date:7/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), a leading developer ... report financial results for the fourth quarter and fiscal ... close of market. The company will host a corresponding ... PT (5:00 p.m. ET), during which management may discuss ... live call, analysts and investors should dial 888-455-2260 (conference ...
(Date:7/8/2015)... 8, 2015 Summary Pancreatic cancer is ... most fatal, with a mortality rate of 10.9 deaths ... pancreatic cancer patients has highlighted a significant need for ... being met by the current market. A highly ... with varying molecule types and mechanisms of action, which ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... period of torpor to conserve energy when resources are scarce. ... champion by far among vertebrates is the burrowing frog ( ... in the mud in the absence of any food or ... scientists at the University of Queensland have discovered that the ...
... new arsenal for meningitis treatment and the war on ... developed by scientists at the Institute of Bioengineering and ... Nanotechnology . The stable bioengineered nanoparticles devised at ... cells that could cause fatal infections and are highly ...
... new song from a member of its own species, the experience ... The sequential switching on and off of thousands of genes after ... memory in the songbird brain. The finding, detailed this month ... was a surprise, said principal investigator David Clayton, a professor of ...
Cached Biology News:Super-sleepers could help super-sizers! 2Singapore nanotechnology combats fatal brain infections 2Researchers see evidence of memory in the songbird brain 2
... combines 2 products into 1:, , A ... isolation kit , ,The FastPrep System ... Qbiogene/BIO101 System Matrix and Isolation Kits. Samples ... tubes eliminating the use of metal probes ...
Abgene's ALTO-8 is the first automated decapper/capper for Abgene Twist-Lock tubes....
Sterile, individually wrapped, 4mm Cuvettes...
... III RNase H- Reverse ... improved version of SuperScript™ ... Like SuperScript™ II it ... strand from single-stranded RNA ...
Biology Products: